GAMMA-GLUTAMYL CYSTEINE SYNTHETASE UP-REGULATES GLUTATHIONE AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN IN PATIENTS WITH CHEMORESISTANT EPITHELIAL OVARIAN-CANCER

Citation
J. Kigawa et al., GAMMA-GLUTAMYL CYSTEINE SYNTHETASE UP-REGULATES GLUTATHIONE AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN IN PATIENTS WITH CHEMORESISTANT EPITHELIAL OVARIAN-CANCER, Clinical cancer research, 4(7), 1998, pp. 1737-1741
Citations number
36
Categorie Soggetti
Oncology
Journal title
ISSN journal
10780432
Volume
4
Issue
7
Year of publication
1998
Pages
1737 - 1741
Database
ISI
SICI code
1078-0432(1998)4:7<1737:GCSUGA>2.0.ZU;2-B
Abstract
Cellular detoxification, such as that mediated by the glutathione (GSH ) system, is involved in the metabolism of various cytotoxic agents, L ittle is known, however, about the clinical relevance of cellular deto xification in chemoresistance, To elucidate the relevance of the GSH s ystem to the resistance to chemotherapy observed in patients with ovar ian cancer, we assayed the expression of mRNA encoded by the multidrug resistance-associated protein (MRP) and gamma-glutamyl cysteine synth etase (gamma-GCS) genes, as well as the level of GSH protein in 32 pat ients with epithelial ovarian cancer after chemotherapy, Tumors of 14 of the 32 patients responded to chemotherapy, whereas 18 did not. The levels of MRP and gamma-GCS transcripts in tumors from nonresponders w ere each about 2-fold higher than in responders. In contrast, the leve l of GSH did not differ between the two groups, We observed coordinate d expression of gamma-GCS mRNA and GSH protein levels, and between gam ma-GCS and MRP in nonresponders, but not in responders. Expression of MRP-encoded mRNA did not correlate to GSH level, however, in either gr oup, These results suggest that gamma-GCS may up-regulate GSH and MRP expression in tumors unresponsive to chemotherapeutic agents, and that the GSH system may be involved in the mechanism of chemoresistance in ovarian cancer.